Actively Recruiting

Early Phase 1
Age: 18Years - 30Years
All Genders
Healthy Volunteers
NCT06499844

Comparing Approaches to Assess Nitric Oxide-dependent Cutaneous Vasodilation

Led by University of Iowa · Updated on 2025-08-24

56

Participants Needed

1

Research Sites

108 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The increase in skin blood flow in response to rapid local heating of the skin (i.e., cutaneous vasodilation) is commonly used to assess nitric oxide (NO)-dependent dilation and overall microvascular function. Historically, rapid local heating to 42°C was considered the standard approach for these assessments. More recently, many investigators have adopted rapid local to 39°C instead, based on its larger dependency on NO and therefore improved ability to quantify NO-dependent dilation without the use of pharmacological techniques. However, to date, only one direct methodological comparison between these protocols has been performed. In this study, the investigators use the blood vessels in the skin as a representative vascular bed for examining mechanisms of microvascular dysfunction in humans. Using a minimally invasive technique (intradermal microdialysis for the local delivery of pharmaceutical agents) they examine the blood vessels in a nickel-sized area of the skin in young adults ages 18 - 30 years old. Local heating of the skin at the microdialysis sites is used to explore differences in mechanisms governing microvascular control. As a compliment to these measurements, the investigators also have participants fill out a variety of surveys to assess things such as sleep quality, physical activity, daily stressors, etc.

CONDITIONS

Official Title

Comparing Approaches to Assess Nitric Oxide-dependent Cutaneous Vasodilation

Who Can Participate

Age: 18Years - 30Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Men and women
  • Between 18 and 30 years of age
Not Eligible

You will not qualify if you...

  • Current or recent (within 8 weeks) use of medications that could affect microvascular function, including stimulants, antihypertensives, or cholesterol-lowering drugs
  • Changes in medication status, such as starting a new medication or changing doses
  • Unstable or diagnosed chronic diseases, including cardiovascular, metabolic, kidney, liver, autonomic, autoimmune, or skin diseases like hypertension, heart disease, diabetes, hyperlipidemia, or psoriasis
  • Body mass index below 18.5 or above 35 kg/m2
  • Pregnancy or breastfeeding
  • Known allergies to study drugs or pharmacological agents
  • Not able to understand English well enough to follow study procedures and instructions

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University of Iowa

Iowa City, Iowa, United States, 52242

Actively Recruiting

Loading map...

Research Team

A

Anna Stanhewicz, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

BASIC_SCIENCE

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here